Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18. Dezember 2024 16:30 ET
|
Neuronetics
MALVERN, Pa., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced the granting of inducement awards to a new employee as described below. In accordance...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
16. Dezember 2024 16:30 ET
|
Neuronetics
MALVERN, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced the granting of inducement awards to new employees as described below. In accordance...
Neuronetics and Greenbrook TMS Announce Closing of Transaction
10. Dezember 2024 10:00 ET
|
Neuronetics
MALVERN, Pa. and TORONTO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics”) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) (“Greenbrook”, and together with Neuronetics,...
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference
20. November 2024 08:30 ET
|
Neuronetics
MALVERN, Pa., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results
12. November 2024 18:45 ET
|
Neuronetics
MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Neuronetics, Inc. (NASDAQ: STIM), please note that in the second paragraph of the...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12. November 2024 16:30 ET
|
Neuronetics
MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results
12. November 2024 07:10 ET
|
Neuronetics
MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of...
Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call
29. Oktober 2024 16:30 ET
|
Neuronetics
MALVERN, Pa., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression
14. Oktober 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents
25. September 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...